PMID: 42556625

The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity.

Roskoski Robert

Pharmacological research · 2026

Vol. 231, pp. 108365

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.